Walgreens Boots Alliance Settles with U.S. Justice Department for $300 Million Over Allegations of Unlawful Opioid Dispensing Practices

Walgreens Boots Alliance has reached a settlement with the U.S. Justice Department, agreeing to pay $300 million to resolve allegations related to the unlawful dispensing of opioids and other controlled substances. The settlement addresses claims that the pharmacy chain filled millions of invalid prescriptions over a period exceeding ten years. The Justice Department, in collaboration with other federal agencies, contends that Walgreens pharmacists were aware of the illegitimacy of these prescriptions but proceeded to fill them regardless.

The allegations suggest that these practices contributed to the illegal distribution of a significant number of opioid pills and other controlled substances from Walgreens locations. Principal Deputy Assistant Attorney General Brian M. Boynton emphasized the impact of these actions, highlighting the role they played in the broader opioid crisis. The settlement aims to address these issues and prevent similar occurrences in the future.

In addition to the $300 million settlement, Walgreens may be required to pay an additional $50 million if the company undergoes a sale, merger, or transfer before the fiscal year 2032. This stipulation is part of the agreement with the Justice Department, which seeks to ensure accountability and compliance with federal regulations.

Despite the settlement, Walgreens maintains its stance against the allegations. A spokesperson for the company, Fraser Engerman, stated that Walgreens disagrees with the government’s legal theory and does not admit to any liability. The company’s decision to settle is not an admission of wrongdoing but rather a resolution to move past the legal challenges.